Phase I/II Clinical Trial of Carbon Ion Radiotherapy for Malignant Gliomas: Combined X-Ray Radiotherapy, Chemotherapy, and Carbon Ion Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 2, 2007, Pages 390-396

  Mizoe, Jun Etsu ^a   Tsujii, Hirohiko ^a   Hasegawa, Azusa ^a   Yanagi, Tsuyoshi ^a   Takagi, Ryo ^a   Kamada, Tadashi ^a   Tsuji, Hiroshi ^a   Takakura, Kintomo ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Carbon ion radiotherapy; High LET radiotherapy; HIMAC; Malignant gliomas; Phase I II clinical trial

Indexed keywords

DOSIMETRY; ONCOLOGY; PATIENT MONITORING;

CARBON ION RADIOTHERAPY; GLIOBLASTOMA MULTIFORME (GBM); MALIGNANT GLIOMAS;

RADIOTHERAPY;

CARBON; NIMUSTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; GLIOBLASTOMA; HUMAN; ION THERAPY; MALE; MULTIMODALITY CANCER THERAPY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; X RAY;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; ASTROCYTOMA; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MIDDLE AGED; NIMUSTINE; RADIOTHERAPY DOSAGE;

EID: 34548484610     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.03.003     Document Type: Article

References (24)

1. Behin A., Hoang-Xuan K., Carpentier A.F., et al. Primary brain tumors in adults. Lancet 361 (2003) 323-331
2. Laperriere N., Zuraw L., Cairncross G., et al. Radiotherapy for newly diagnosed malignant gliomas in adults: A systemic review. Radiother Oncol 64 (2002) 259-273
3. Glioma meta-analysis trialists (GMT) group. Lancet 359 (2002) 1011-1810
4. Liu Z., Yu X., Guo Y., et al. Interstitial brachytherapy using iridium-192 for malignant brain tumors: Clinical results. Chin Med J 112 (1999) 139-142
5. Videtic G.M.M., Caspar L.E., Zamorano L., et al. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Radiat Oncol Biol Phys 45 (1999) 687-692
6. Svensson H., and Landberg T. Neutron therapy - The historical background. Acta Oncologica 33 (1994) 227-231
7. Mizoe J.E., Aoki Y., Morita S., et al. Fast neutron therapy for malignant gliomas-Results from NIRS study. Strahlenther Onkol 169 (1993) 222-227
8. Griffin T.W. Fast neutron radiation therapy. Crit Rev Oncol/Hematol 13 (1992) 17-31
9. Wambersie A., Richard F., and Breteau N. Development of fast neutron therapy worldwide. Acta Oncol 33 (1994) 261-274
10. Laramore G.E. The use of neutrons in cancer therapy: A historical perspective through the modern era. Semin Oncol 24 (1997) 672-685
11. Castro J.R., Philips T.L., Prados M., et al. Neon heavy charged particle radiotherapy of glioblastoma of the brain. Int J Radiat Oncol Biol Phys 38 (1997) 257-261
12. Hirao Y., Ogawa H., Yamada S., et al. Heavy ion synchrotron for medical use. (HIMAC project at NIRS, Japan). Nuclear Physics A538 (1992) 541c-550c
13. Tsujii H., Morita S., Miyamoto T., et al. Preliminary results of Phase I/II carbon-ion therapy at the National Institute of Radiological Sciences. J Brachyther Int 13 (1997) 1-8
14. Kanai T., Endo M., Minohara S., et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys 44 (1999) 201-210
15. Tanaka M., Shibui S., Nomura K., et al. Radiotherapy combined with nimustine hydrocholoride and etoposide for malignant gliomas: Results of a pilot study. Jpn J Oncol 31 (2001) 246-250
16. Hauch H., Sajedi M., and Wolff J.E. Treatment arms summarizing analysis of 220 high-grade glioma studies. Anticancer Res 25 (2005) 3585-3590
17. Pavy J.J., Denekamp J., Letschert J., et al. Late effect toxicity scoring: The SOMA scale. (EORTC Late Effects Working Group). Radiother Oncol 35 (1995) 11-15
18. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457
19. Curran W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant gliomas trials. Int J Radiat Oncol Biol Phys 85 (1993) 704-710
20. Laramore G.E., Diener-West M., Griffin T.W., et al. Randomized neutron dose searching study for malignant gliomas of the brain: Results of an RTOG study. Int J Radiat Oncol Biol Phys 14 (1988) 1093-1103
21. Iuchi T., Hatano K., Narita Y., et al. Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT. Int J Radiat Oncol Biol Phys 64 (2006) 1317-1324
22. Hsieh P.C., Chandler J.P., Bhangoo S., et al. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 57 (2005) 684-692
23. Magrini S.M., Ricardi U., Santoni R., et al. Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers. Int J Radiat Oncol Biol Phys 65 (2006) 788-799
24. Tanaka M., Ino Y., Nakagawa K., et al. High-dose conformal radiotherapy for supratentorial malignant gliomas: A historical comparison. Lancet Oncol 6 (2005) 953-960